Emerging research suggest Retatru tide , a dual agonist targeting both the gut-brain axis and glucose-dependent get more info insulinotropic polypeptide , could represent a significant step forward for weight management . Initial patient tests have indicated substantial decreases in body fat , conceivably surpassing current obesity medications . Ho